Invent Ventures (IDEA) Stock Price, News & Analysis

Company Overview

Invent Ventures, Inc. (OTCMKTS:IDEA) is a medical device and life-science technology company specializing in the design, development and manufacturing of respiratory care and drug delivery solutions. The company’s core product portfolio includes non-invasive and invasive ventilators, ultrasonic and mesh nebulizers, oxygen flow meters and aerosol drug-formulation platforms. By integrating advanced engineering with clinical insights, Invent Ventures aims to enhance patient outcomes in both hospital and home-care settings.

In addition to its proprietary respiratory therapy devices, Invent Ventures offers contract research and manufacturing services for original equipment manufacturers (OEMs) in the pharmaceutical and medical device sectors. These services encompass product design, prototyping, regulatory support and scalable production. The company’s flexible manufacturing capabilities allow it to serve a diverse clientele, from emerging biotech firms seeking to bring novel inhalation therapies to market to established medical-device companies requiring high-volume assembly.

Headquartered in Irvine, California, Invent Ventures maintains research and production facilities in North America and Asia Pacific, with distribution channels extending into Europe, Latin America and select markets in the Middle East. The company works closely with hospital systems, home-health providers and strategic partners to ensure its products meet regional regulatory standards and address local clinical needs. Its global footprint supports responsive customer service and supply-chain resilience.

Founded in 2007 by a group of biomedical engineers and respiratory therapists, Invent Ventures is led by a management team with extensive experience in medical-device innovation, regulatory affairs and global operations. The executive leadership emphasizes continuous investment in R&D, adherence to quality-management systems and collaboration with key opinion leaders. Through ongoing product enhancements and new technology development, the company seeks to address unmet needs in respiratory care and drug delivery worldwide.

Key Stats

• Today's Range: $0.0150 to $0.0150
• 50-Day Range: $0.01 to $0.0150
• 52-Week Range: $0.01 to $0.03
• Volume: N/A
• Average Volume: 8,921 shs
• Market Capitalization: $1.42 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IDEA Stock Analysis - Frequently Asked Questions

How have IDEA shares performed this year?

Invent Ventures' stock was trading at $0.0145 at the beginning of the year. Since then, IDEA shares have increased by 3.4% and is now trading at $0.0150.

How do I buy shares of Invent Ventures?

Shares of IDEA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Invent Ventures own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Invent Ventures investors own include Planet Labs PBC (PL), Opendoor Technologies (OPEN), NerdWallet (NRDS), Lithium Americas (LAC), Ford Motor (F), Energy Transfer (ET) and CrowdStrike (CRWD).

Company Calendar

• Today: 7/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Finance
• Industry: FIN - SBIC&COMMRL
• Sub-Industry: Computer Hardware
• Current Symbol: OTCMKTS:IDEA
• CIK: N/A
• Web: www.invent.vc
• Phone: (702) 943-0330
• Fax: N/A
• Employees: 9
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $710 thousand
• Net Margins: 91.12%
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $790 thousand
• Price / Sales: 1.80
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 94,660,000
• Free Float: 76,266,000
• Market Cap: $1.42 million
• Optionable: Not Optionable
• Beta: -49.63